BCDA biocardia.com: Operating Profitability

BioCardia Inc (BCDA) - corporate logo

BioCardia, Inc. (BCDA) is developing a niche in heart failure therapy by creating specialized cell delivery systems. However, the business relies critically on the success of final trials for a single product, which creates binary risk. The operating margin shown on this chart demonstrates current cost efficiency, where the metric is fixed at 0.00, considering the impact of geopolitical patent disputes and logistical disruptions in Asia.

BCDA: BioCardia Inc. Operating Sales Margin 07/04/2022 - 11/19/2026

Comprehensive metric breakdowns and analytics for BioCardia, Inc. (BCDA)

- share price and consensus valuation forecast:
- company stock capitalization data:
Comprehensive company analysis:BioCardia, Inc., BCDA
Finished products of BioCardia Inc

Operating margin measures the efficiency of the core business by determining the portion of profit before taxes and interest in every dollar of revenue. By analyzing the operating profit margin, an investor sees the actual profitability, which for BioCardia, Inc. (BCDA) remains critically low due to massive clinical trial expenses and a lack of sustainable market barriers.